BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6225469)

  • 1. [Fibrinogen fragment D - inhibitor of fibrinolytic processes].
    Rozenfel'd MA; Fateeva LA; Gontar' ID
    Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced in vitro fibrinolytic activity of immobilized plasmin on collagen beads.
    Shankar H; Senatore F; Zuniga P; Venkataramani E
    J Biomed Mater Res; 1987 Jul; 21(7):897-912. PubMed ID: 2440893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
    Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
    Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis.
    Ge M; Tang G; Ryan TJ; Malik AB
    J Clin Invest; 1992 Dec; 90(6):2508-16. PubMed ID: 1281836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The hydrolysis of Glu(gamma-epsilon)Lys-amide bonds in D-dimer fragment of fibrin by destabilase from medicinal leech].
    Baskova IP; Zavalova LL; Basanova AV; Grigor'eva OV
    Bioorg Khim; 1999 Jun; 25(6):435-8. PubMed ID: 10505231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.
    Smith RA; Dupe RJ; English PD; Green J
    Thromb Haemost; 1982 Jun; 47(3):269-74. PubMed ID: 6214039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antifibrinolytic effect of heparin].
    Rozenfel'd MA; Leonova VB; Khavkina LS; Meshkov BB
    Biokhimiia; 1984 Oct; 49(10):1672-8. PubMed ID: 6240283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition].
    Platonova TN; Musialkovskaia AA; Tolstykh VM; Belitser VA
    Biokhimiia; 1980 Oct; 45(10):1780-7. PubMed ID: 7236767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin.
    Kolev K; Gombás J; Váradi B; Skopál J; Mede K; Pitlik E; Nagy Z; Machovich R
    Thromb Haemost; 2002 Mar; 87(3):502-8. PubMed ID: 11916083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.